GAS Pharyngitis Diagnostics Market

Global GAS Pharyngitis Diagnostics Market “By Product (Rapid Kit Test, Culture Test and PCR-Based Test); By End-User (Physician Clinics, Diagnostic Laboratories, Hospitals and Others)” - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

A prominent research firm, Cognizance Market Research added a cutting-edge industry report on the ” Global GAS Pharyngitis Diagnostics market”. The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2023 to 2030.

Global GAS Pharyngitis Diagnostics Market Analysis

According to cognizance market research, The Global GAS Pharyngitis Diagnostics Market was valued at US$ 178.3 Million in 2022 and is anticipated to reach US$ 214.6 Million by the end of 2030 with a CAGR of 2.3% from 2023 to 2030.

What is GAS Pharyngitis Diagnostics?

Gas pharyngitis manifests as a specific form of inflammation affecting the posterior throat region, specifically the pharynx. This condition stems from the activity of Group A streptococcus (GAS) bacteria and can lead to grave implications if left unattended. Often recognized as strep throat, GAS pharyngitis typically surfaces during late winter and exhibits prevalence across diverse age groups, encompassing both newborns and elderly adults. The spectrum of symptoms associated with this bacterial infection encompasses fever, a sore throat, abdominal discomfort, sensations of nausea, instances of vomiting, reddened eyes, and episodes of diarrhea. Notably contagious, the infection possesses a marked propensity for swift transmission through direct contact with an infected individual. This characteristic renders places like educational institutions and military academies particularly susceptible to its propagation.

The diagnostic journey for GAS pharyngitis incorporates an amalgamation of methods, including physical examination, a comprehensive medical history assessment, and laboratory tests. Among the arsenal of diagnostic tools, rapid strep testing and throat cultures emerge as salient contenders. These methodologies boast heightened sensitivity levels, augmenting their efficacy in pinpointing the presence of GAS bacteria and confirming the diagnosis of GAS pharyngitis.

Global GAS Pharyngitis Diagnostics Market Outlook

In the Global GAS pharyngitis diagnostics report, the market outlook segment mainly includes important dynamics of the market which include drivers, restraints, opportunities and challenges tackled by the industry. Opportunities and challenges are extrinsic factors whereas, drivers and restraints are intrinsic factors of the market.

Growth in the market is predicted to be fueled by an increase in the number of deaths caused by rheumatic heart disease, particularly in industrialised areas. Group A streptococcus bacteria, which cause strep throat and scarlet fever, are the cause of the illness.

Strong government policies, an increase of foreign direct investments, and significant local work being done in the diagnostics industry all point to tremendous success for the GAS pharyngitis market.

Growing consumer preference for advanced healthcare mechanisms over conventional methods of treatment combined with increasing consumer awareness of newly developed diagnostic techniques is likely to give the GAS pharyngitis diagnostic market the much-needed boost.

Consumer movements are more likely to occur in nations with robust purchasing power parity and favourable reimbursements.

Due to the numerous difficulties in diagnosing GAS pharyngitis, the market is expected to be hindered. The most crucial of these is giving precise, detailed, and effective diagnostic results.

Additionally, the market penetration may be hampered by a lack of knowledge about recently established diagnostic tools combined with a broad range of myths circulating in third world countries and regions with unsettled politico-legal dynamics.

Clinical trials have been cancelled and new diagnostic product introductions have been delayed as the whole healthcare infrastructure has been redirected towards combating COVID-19 and its impacts. This could further impede the demand for diagnostic tests for GAS pharyngitis.

Segment Analysis:

The Global GAS pharyngitis diagnostics market has been segmented into product, end-user and geography.

Based on product, the GAS pharyngitis diagnostics market has been segmented into rapid kit test, culture test and PCR-based test. The rapid test kit category led the global market for GAS pharyngitis diagnostics. The development of rapid point-of-care diagnostics, which will mostly be employed in medical clinics and hospitals, can be credited with the segment’s growth. Additionally, the category is projected to grow in popularity because to its simplicity of use and low cost per test.

Based on end-user, the market for GAS pharyngitis diagnostics has been classified into physician clinics diagnostic laboratories, hospitals and others. In terms of end users, hospitals and physician’s clinics are expected to be very lucrative segments between 2023 and 2030. One of the key reasons why the hospitals segment is anticipated to dominate the market share is the high volume of immunoassay reagents and test kits used in hospitals for the diagnosis of GAS pharyngitis.

Geographical Analysis:

Based on geography the Global GAS pharyngitis diagnostics market has been segmented into five main regions namely, North America, Asia Pacific, Europe, Latin America, and Middle East & Africa.

Gas pharyngitis is extremely common in North America, where there is also a well-developed healthcare system, making the region the greatest market for diagnostics at the moment. Due to the high prevalence of streptococcal pharyngitis, the most prevalent kind of gas pharyngitis, the United States represents a significant market for gas pharyngitis diagnostics.

Europe is a sizable market for gas pharyngitis diagnostics, with prominent companies in the region including Germany, France, and the United Kingdom. In Europe, the market is expanding because to the increased prevalence of bacterial illnesses and a rising demand for quick diagnostic testing.

Gas pharyngitis is becoming more common, patients and healthcare professionals are becoming more aware of it, and the region’s healthcare infrastructure is improving, all of which are contributing to the market for diagnostics for the condition predicted to develop significantly in the Asia-Pacific. The two markets in the region expected to develop the fastest are those in China and India.

Due to the high frequency of bacterial diseases and rising investments in healthcare infrastructure in Latin America and the Middle East and Africa (MEA), the market for gas pharyngitis diagnostics is also anticipated to expand significantly in these regions.

The report offers the revenue of the global GAS pharyngitis diagnostics market for the period 2020-2030, considering 2020 & 2021 as a historical years, 2022 as the base year and 2023 to 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global GAS pharyngitis diagnostics market for the forecast period. The global GAS pharyngitis diagnostics market report provides insights and in-depth analysis into developments impacting enterprises and businesses on a regional and global level. The report covers the global GAS pharyngitis diagnostics market performance in terms of revenue contribution from several segments and comprises a detailed analysis of key drivers, trends, restraints, and opportunities prompting revenue growth of the global GAS pharyngitis diagnostics market.

The report has been prepared after wide-ranging secondary and primary research. Secondary research included internet sources, numerical data from government organizations, trade associations, and websites. Analysts have also employed an amalgamation of bottom-up and top-down approaches to study numerous phenomena in the GAS pharyngitis diagnostics market. Secondary research involved a detailed analysis of significant players’ product portfolios. Literature reviews, press releases, annual reports, white papers, and relevant documents have been also studied to understand the GAS pharyngitis diagnostics market. Primary research involved a great extent of research efforts, wherein experts carried out interviews telephonic as well as questioner-based with industry experts and opinion-makers.

The report includes an executive summary, along with a growth pattern of different segments included in the scope of the study. The Y-o-Y analysis with elaborate market insights has been provided in the report to comprehend the Y-o-Y trends in the GAS pharyngitis diagnostics market. Additionally, the report focuses on altering competitive dynamics in the global market. These indices serve as valued tools for present market players as well as for companies interested in participating in the GAS pharyngitis diagnostics market. The subsequent section of the GAS pharyngitis diagnostics report highlights the USPs, which include key industry events (Type launch, research partnership, acquisition, etc.), technology advancements, pipeline analysis, prevalence data, and regulatory scenario.

Global GAS Pharyngitis Diagnostics Market Competitive Landscape

The “Global GAS Pharyngitis Diagnostics Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as –

  • Abbott Laboratories
  • BD
  • Beckman Coulter, Inc. (Danaher)
  • bioMrieux SA
  • Bio-Rad Laboratories
  • DiaSorin S.p.A.
  • Hoffmann-La Roche Ltd
  • Hologic
  • Luminex Corporation
  • Mckesson CONSULT
  • Meridian Bioscience, Inc.
  • Multibrands International Ltd.
  • Quidel Corporatiion
  • Sekisui Diagnostics

Recent developments in the GAS pharyngitis diagnostics market-

  • A distribution and fulfilment agreement with McKesson Corporation, a world leader in healthcare supply chain management solutions was finished on April 23, 2021, according to Quidel Corporation, a leading provider of quick diagnostic testing solutions, cellular-based virology assays, and molecular diagnostic systems.
  • In Mar 16, 2021, Roche agreed to buy GenMark Diagnostics, a provider of molecular diagnostic solutions with headquarters in the United States, for $24.05 per share, or approximately $1.8 billion, in an all-cash deal.

The report explores the competitive scenario of the GAS pharyngitis diagnostics market. Major players operating in the GAS pharyngitis diagnostics market have been identified and profiled for unique commercial attributes. Company overview (company description, Type portfolio, geographic presence, employee strength, Key management, etc.), financials, SWOT analysis, recent developments, and key strategies are some of the features of companies profiled in the GAS pharyngitis diagnostics market report.


Global GAS Pharyngitis Diagnostics Market, by Product

  • Rapid Test Kit
  • Culture Test
  • PCR-Based Test

Global GAS Pharyngitis Diagnostics Market, by End-User

  • Physician Clinics
  • Diagnostic Laboratories
  • Hospitals
  • Others

Global GAS Pharyngitis Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
Complete the form below and we'll get back to you shortly
Table of Content

Key Questions Answered in GAS Pharyngitis Diagnostics Market Report

The major players operating in the market include Quidel Corporation, BD, Abbott Laboratories, bioMrieux SA, Hoffmann-La Roche Ltd, Beckman Coulter, Inc. (Danaher), Meridian Bioscience, Inc., DiaSorin S.p.A., Sekisui Diagnostics.

North America is the leading region in the market.

A type of pharyngitis, or inflammation of the pharynx, or back of the throat, is gas pharyngitis. Group A streptococcus (GAS), the bacteria that causes gas pharyngitis, can have serious consequences if left untreated.

The segments covered in the GAS pharyngitis market report are product, end-user and geography.

Based on end-user, the hospitals and physician clinics segment leads the market owing to high volume of immunoassay reagents and test kits used in hospitals for the diagnosis of GAS pharyngitis.

cognizance market research(cmr)

GAS Pharyngitis Diagnostics Market

Black Friday Offers (40% Off)​

Don’t Miss Out On The Biggest Savings Of The Year!

- Get Started -

Get insights that lead to new growth opportunities

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png

Black Friday Offers (40% Off)

Don't miss out on the biggest savings of the year!

small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert